1. A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis. Issue 2 (February 2017) Authors: Colleoni, Lara; Galbardi, Barbara; Barzago, Claudia; Bonanno, Silvia; Franzi, Sara; Frangiamore, Rita; Camera, Giorgia; Foti, Maria; Biancolini, Donatella; Canioni, Eleonora; Maggi, Lorenzo; Antozzi, Carlo; Mantegazza, Renato; Bernasconi, Pia; Kapetis, Dimos Journal: Pharmaocogenetics and genomics Issue: Volume 27:Issue 2(2017:Feb.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study. (December 2018) Authors: Bonanno, Silvia; Pasanisi, Maria Barbara; Frangiamore, Rita; Maggi, Lorenzo; Antozzi, Carlo; Andreetta, Francesca; Campanella, Angela; Brenna, Greta; Cottini, Lorenzo; Mantegazza, Renato Journal: SAGE open medicine Issue: Volume 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cognitive function alone is a poor predictor of health-related quality of life in employed patients with MS: results from a cross-sectional study. Issue 2 (17th February 2016) Authors: Giovannetti, Ambra Mara; Schiavolin, Silvia; Brenna, Greta; Brambilla, Laura; Confalonieri, Paolo; Cortese, Francesca; Covelli, Venusia; Frangiamore, Rita; Leonardi, Matilde; Mantegazza, Renato; Moscatelli, Marco; Ponzio, Michela; Torri Clerici, Valentina; Zaratin, Paola; Raggi, Alberto Journal: Clinical neuropsychologist Issue: Volume 30:Issue 2(2016) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine. (October 2019) Authors: Cavalcante, Paola; Mizrachi, Tehila; Barzago, Claudia; Scandiffio, Letizia; Bortone, Federica; Bonanno, Silvia; Frangiamore, Rita; Mantegazza, Renato; Bernasconi, Pia; Brenner, Talma; Vaknin-Dembinsky, Adi; Antozzi, Carlo Journal: Pharmacological research Issue: Volume 148(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis. Issue 19 (11th September 2019) Authors: Raggi, Alberto; Giovannetti, Ambra Mara; Schiavolin, Silvia; Brambilla, Laura; Brenna, Greta; Confalonieri, Paolo Agostino; Cortese, Francesca; Frangiamore, Rita; Leonardi, Matilde; Mantegazza, Renato Emilio; Moscatelli, Marco; Ponzio, Michela; Torri Clerici, Valentina; Zaratin, Paola; De Torres,... Journal: Disability and rehabilitation Issue: Volume 41:Issue 19(2019) Page Start: 2255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. Issue 5 (May 2023) Authors: Howard, James F; Bresch, Saskia; Genge, Angela; Hewamadduma, Channa; Hinton, John; Hussain, Yessar; Juntas-Morales, Raul; Kaminski, Henry J; Maniaol, Angelina; Mantegazza, Renato; Masuda, Masayuki; Sivakumar, Kumaraswamy; Śmiłowski, Marek; Utsugisawa, Kimiaki; Vu, Tuan; Weiss, Michael D; Zajda, M... Journal: Lancet neurology Issue: Volume 22:Issue 5(2023) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Howard, James F; Bril, Vera; Vu, Tuan; Karam, Chafic; Peric, Stojan; Margania, Temur; Murai, Hiroyuki; Bilinska, Malgorzata; Shakarishvili, Roman; Smilowski, Marek; Guglietta, Antonio; Ulrichts, Peter; Vangeneugden, Tony; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato; De Bleeker, Jan;... Journal: Lancet neurology Issue: Volume 20:Issue 7(2021) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Howard, James F; Bril, Vera; Vu, Tuan; Karam, Chafic; Peric, Stojan; Margania, Temur; Murai, Hiroyuki; Bilinska, Malgorzata; Shakarishvili, Roman; Smilowski, Marek; Guglietta, Antonio; Ulrichts, Peter; Vangeneugden, Tony; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato; De Bleecker, Jan... Journal: Lancet neurology Issue: Volume 20:Issue 7(2021) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗